Mirna Therapeutics, Inc. to Moderate Session on Promise of miRNAs in Cancer at Biotechnology Industry Organization (BIO) International Convention

Published: Jun 27, 2011

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. (“Mirna”) announced today that the Company will moderate a session on the role and promise of microRNAs (miRNAs) in cancer during the Biotechnology Industry Organization (BIO) International Convention, which will be held June 27-30, 2011, in Washington DC.

Back to news